The Smart Pills Market is expected to grow on an irreversible note in the next 10 years. The future scenario would be data-driven healthcare. This would, in turn, widen the potential for enhancing treatment options. With interoperability taking the centre stage, program participants could access app blueprints, data templates, and security tools. Thus, the big data cloud would turn out to be kinetic. This would result in an upswing in the healthcare vertical going forward.

The Ingestible Smart Pills Market is expected to go digital ways in the forecast period. With the non-linear journey of the healthcare vertical, personalization is looked upon as the key to effective healthcare. Furthermore, patient portals would be launched as well as refined. Mobile-friendliness would be taken into consideration. Treatment-specific information or recommendation of certain appointments or services would be personalized. This would be the healthcare vertical in the upcoming period.

Advancements in the field of medical technology will continue to be directed towards processes that help manufacturers miniaturize their healthcare products, but without impacting their effectiveness. Persistence Market Research recently published its report on the global market for ingestible smart pills which projects that high demand for miniaturization of diagnostic disorders is driving the demand for ingestible smart pills. By the end of 2024, the global ingestible smart pills market is projected to grow at 7.7% CAGR and reach US$ 1,475.2 Mn in value.

How About Looking Through The Sample Of Ingestible Smart Pills Market Report?

Company Profiles:

Philips Respironics
Given Imaging Ltd.
Olympus Corporation
Proteus Digital Health, Inc.
CapsoVision, Inc.
Chongqing Jinshan Science and Component (Group) Co., Ltd.
IntroMedic Co., Ltd.
Check-Cap Ltd.

How About Step-By-Step Insights To Ingestible Smart Pills Market? Look Through The “Methodology” Employed!

In the report, titled “Ingestible Smart Pills Market: Global Industry Analysis and Forecast, 2016-2024,” the global demand for ingestible smart pills is predicted to surge on the account of following factors:

Increasing Prevalence of Gastrointestinal Disorders: The report estimates that in a region like North America, more than 60 million people are annually diagnosed with gastrointestinal diseases. Early diagnosis of such disorders compels the use of proper endoscopic treatment, which incidentally necessitates the use of ingestible smart pills.

Availability of Accurate Data on Ingestible Smart Pills: Being the next big frontier in novel medical imaging & monitoring technology, ingestible smart pills are being extensively researched and compatible software for deriving data from these pills is being developed, and simultaneously upgraded.

Component Advancements in Endoscopy: New endoscopic components developed by research institutes are treading along the trend of product miniaturization, supporting the inclusion of ingestible smart pills in endoscopic therapies.

According to the report, more than 80% of global ingestible smart pill revenues will be emanating from sales of smart pills, as opposed to workstations. Demand for workstations is expected to witness a downtrend towards the latter half of the forecast period. The report reveals that eight out of ten ingestible smart pills produced in the world will be used for medical imaging applications.

In 2016, more than US$ 800 Mn worth of ingestible smart pills were accounted by medical imaging applications. The present value of global ingestible smart pills market is estimated to be US$ 958.2 Mn. By 2024-end, around 17% of this value will be attributed by revenues arising from sales of ingestible smart pills in health monitoring applications.

Want To Keep A Tab On The Latest Findings In The Ingestible Smart Pills Market? Purchase Our Ingestible Smart Pills Market Report Now!

The report also reveals that hospitals are the largest end-users of ingestible smart pills in the world. With more than 43% share, manufacturers of ingestible smart pills will continue directing their sales towards hospitals. Demand for ingestible smart pills is also expected to gain traction among clinics. In 2017 and beyond, North America will be observed as the most dominant region in the global ingestible smart pill market. Although, the ingestible smart pills market in Asia-Pacific is expected to register speedy revenue growth at over 6% CAGR.

PMR Exclusive Reports-

Telemedicine Market:

Bioabsorbable Implants Market:

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.